Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
McGill University
$105,000.00
Inflammatory caspases in the pathogenesis of chronic proliferative dermatitis in mice
FY 2014-15
Summary
The inflammasome is a pattern recognition receptor complex which acts in the innate immune system by sensing and reacting to pathogen invasion, metabolic perturbations and tissue damage. Though critical for host defence, deregulation of these responses is associated with chronic sterile and infectious inflammatory diseases. Chronic proliferative dermatitis in mice (CPDM) is a spontaneous inflammatory animal model with pathological hallmarks similar to atopic dermatitis in humans, and my project explores the environmental and molecular mechanisms of disease in this context, and interrogates the role of cell death and innate immunity in its pathogenesis. While skin inflammation in CPDM mice has been shown to be driven by TNFR1-mediated cell death, the relative contribution of additional inflammatory and cell death pathways remains poorly characterized. This is of therapeutic significance as TNF-directed therapy in atopic dermatitis patients is inconsistently effective. I have uncovered a central role of the inflammasome in disease progression by showing that ablation of the inflammasome caspases-1 and -11 rescues the CPDM dermatitis phenotype. CPDM mice develop disease due to lack of Sharpin expression, an adaptor protein of the Linear Ubiquitin Assembly Complex (LUBAC) which acts to promote cell survival and inflammation via linear ubiquitination of key substrates. Preliminary results indicate that primary macrophages from CPDM mice exhibited enhanced inflammasome activation following ex vivo stimulation and that caspase-1 is linearly ubiquitinated by LUBAC. We therefore hypothesize that CPDM pathogenesis is in part driven by aberrant activation of the inflammasome pathway in the skin downstream of TNF-driven cell death and that LUBAC directly inhibits inflammasome activation by targeting caspase-1 for linear ubiquitination.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
332332
Name
Douglas Todd
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Inflammatory caspases in the pathogenesis of chronic proliferative dermatitis in mice
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Biochemistry; Cell Death; Dermatitis; Inflammasome; Innate Immune Regulation; Microbiota; Ubiquitination
Abstract
The inflammasome is a pattern recognition receptor complex which acts in the innate immune system by sensing and reacting to pathogen invasion, metabolic perturbations and tissue damage. Though critical for host defence, deregulation of these responses is associated with chronic sterile and infectious inflammatory diseases. Chronic proliferative dermatitis in mice (CPDM) is a spontaneous inflammatory animal model with pathological hallmarks similar to atopic dermatitis in humans, and my project explores the environmental and molecular mechanisms of disease in this context, and interrogates the role of cell death and innate immunity in its pathogenesis. While skin inflammation in CPDM mice has been shown to be driven by TNFR1-mediated cell death, the relative contribution of additional inflammatory and cell death pathways remains poorly characterized. This is of therapeutic significance as TNF-directed therapy in atopic dermatitis patients is inconsistently effective. I have uncovered a central role of the inflammasome in disease progression by showing that ablation of the inflammasome caspases-1 and -11 rescues the CPDM dermatitis phenotype. CPDM mice develop disease due to lack of Sharpin expression, an adaptor protein of the Linear Ubiquitin Assembly Complex (LUBAC) which acts to promote cell survival and inflammation via linear ubiquitination of key substrates. Preliminary results indicate that primary macrophages from CPDM mice exhibited enhanced inflammasome activation following ex vivo stimulation and that caspase-1 is linearly ubiquitinated by LUBAC. We therefore hypothesize that CPDM pathogenesis is in part driven by aberrant activation of the inflammasome pathway in the skin downstream of TNF-driven cell death and that LUBAC directly inhibits inflammasome activation by targeting caspase-1 for linear ubiquitination.
Competitiondate
201410
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Douglas, Todd
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~